Cationic porphyrinyl covalent organic framework as well as preparation method and targeted sterilization application thereof

The cationic porphyrin-based covalent organic framework TAPP-VIO synthesized by Schiff base reaction solvent-thermal method solves the problem of self-aggregation and lack of targeting in the physiological environment, and achieves efficient photothermal and photodynamic sterilization. Enhance the therapeutic effect and ensure biosafety.

CN118930782AActive Publication Date: 2024-11-12JIANGNAN UNIV
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202410980451.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-12
Estimated Expiration
2044-07-22

AI Technical Summary

Technical Problem

Existing photosensitizers are prone to aggregation and self-quenching in physiological environments, lacking bacterial targeting, resulting in poor treatment effects, and the efficiency of light treatment is limited by the penetration depth of light and oxygen depletion.

Method used

The cationic porphyrin-based covalent organic framework TAPP-VIO was synthesized by Schiff base reaction solvent thermal method, through 5,10,15,20-tetra-(4-aminophenyl)porphyrin and 4,4'-dibenzene Formaldehyde-bipyridine reaction prepares materials with photothermal/photodynamic/chemical bactericidal capabilities, and uses its special pore structure and cationic repulsion to reduce self-aggregation of photosensitizers, enhancing photothermal conversion performance and oxygen storage capacity.

Benefits of technology

Effectively prevent photosensitizers from self-aggregation and quenching, improve the effects of photothermal and photodynamic treatment, achieve efficient targeted sterilization of bacteria, and have good biosafety of the material.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930782A_ABST
    Figure CN118930782A_ABST
Patent Text Reader

Abstract

The invention relates to a preparation method and application of a porphyrinyl covalent organic framework TAPP-VIO with photo-thermal / photodynamic / chemical sterilization, and belongs to the technical field of advanced functional materials and biological medicines. 5, 10, 15, 20-tetra-(4-aminophenyl) porphyrin (TAPP) is used as a structural unit for synthesizing the covalent organic framework, so that the distance of a photosensitizer is limited, meanwhile, the covalent organic framework is endowed with photosensitive activity, and meanwhile, certain electrostatic repulsive force and bacterial targeting property are endowed between material layers through another structural unit 4, 4 '-dibenzaldehyde-dipyridyl (VIO); and a bacterial reaction targeting material integrating photo-thermal / photodynamic / chemical sterilization capabilities is constructed. The photo-thermal / photodynamic / chemical sterilization integrated material has good stability, bacterial targeting, photo-thermal heating effect and excellent active oxygen generation capacity, has good biological safety and has huge potential in the aspect of bacterial infection treatment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a preparation method and application of a porphyrin-based covalent organic framework TAPP-VIO with photothermal / photodynamic / chemical sterilization, belonging to the technical field of advanced functional materials and biomedicine. Background Art

[0002] Bacterial infection is an acute systemic infection caused by pathogenic bacteria or conditional pathogens invading the blood circulation from wounds or infected lesions in the body, growing and multiplying, and producing toxins and other metabolites. The scope of its spread can reach all tissues and organs in the body, such as epidermal bacterial infection and deep tissue and organ infection. Elderly people, children, those with chronic diseases or immunosuppression may develop sepsis or septicemia, which seriously threatens human health and social development. The emergence of antibiotics has initially alleviated this problem and achieved some results in the treatment of bacterial infections. However, with the extensive use of antibiotics, its shortcomings have gradually been exposed, such as low bioavailability, strong toxic side effects, bacterial resistance, etc. Therefore, there is an urgent need to develop a new treatment for bacterial infections that is efficient and does not produce drug resistance.

[0003] Photo-sterilization is a promising treatment method, which has attracted much attention due to its advantages such as non-invasiveness, simple operation, high specificity, low invasiveness, few side effects and no drug resistance. Photo-sterilization includes photothermal sterilization and photodynamic sterilization. It is a method that converts light energy into heat energy or reactive oxygen through photosensitizers, causing irreversible damage to bacteria, thereby achieving therapeutic effects. However, most photosensitizers lack bacterial targeting and specificity, resulting in poor therapeutic effects and non-specific damage to normal tissues. In addition, most photosensitizers have problems such as self-aggregation quenching and poor photostability in physiological environments, resulting in unsatisfactory therapeutic effects. In addition, the efficiency of phototherapy is also subject to limitations such as limited penetration depth of light and oxygen depletion. Therefore, it is urgent to develop a new type of phototherapy agent that does not produce aggregation self-quenching, can target bacteria, and has high-efficiency sterilization for the treatment of bacterial infections. Summary of the invention

[0004] In order to solve the above problems, the purpose of the present invention is to provide a new type of light sterilization material TAPP-VIO, which is synthesized based on the Schiff base reaction solvothermal method, has bacteria-specific targeting, and integrates photothermal / photodynamic / chemical sterilization. It overcomes and solves the problems of unsatisfactory therapeutic effects caused by traditional photosensitizers such as easy aggregation and quenching under physiological conditions, lack of targeting, and limited therapeutic efficiency.

[0005] The technical solution of the present invention:

[0006] The first aspect of the present invention is to provide a cationic porphyrin-based covalent organic framework having photothermal / photodynamic / chemical synergistic bactericidal ability, wherein the cationic porphyrin-based covalent organic framework has a structure shown in Formula I;

[0007]

[0008] Further, the cationic porphyrin-based covalent organic framework (TAPP-VIO) is prepared by reacting 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin monomer (TAPP) with 4,4'-dibenzaldehyde-bipyridine monomer (VIO);

[0009] Further, the 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin monomer (TAPP) has a structure shown in Formula II;

[0010] Further, the 4,4'-dibenzaldehyde-bipyridine monomer (VIO) has a structure shown in Formula III;

[0011]

[0012] The second aspect of the present application is to provide a method for preparing the cationic porphyrin-based covalent organic framework (TAPP-VIO) material; the method comprises the steps of: mixing a solution containing 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin with a solution containing 4,4'-dibenzaldehyde-bipyridine, then adding an acid or a base as a catalyst, mixing evenly, reacting at a certain temperature, separating, washing and drying to obtain the product TAPP-VIO.

[0013] Furthermore, the preparation method of TAPP-VIO material adopts acid-base assisted solvothermal method, and the specific steps are as follows:

[0014] (1) mixing a solution containing 4,4'-dibenzaldehyde-bipyridine (VIO), 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin (TAPP) and mesitylene / n-butanol at room temperature, then adding a catalyst and continuing to mix uniformly to obtain a reaction solution;

[0015] (2) reacting the reaction solution at 60-150° C. for 2-7 days;

[0016] (3) After the reaction is completed, centrifugation, washing, and drying are performed to obtain the porphyrin-based covalent organic framework material (TAPP-VIO).

[0017] In some preferred embodiments, the molar ratio of the 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin to the 4,4'-dibenzaldehyde-bipyridine is 1:2.

[0018] Furthermore, the reaction is carried out in an organic solvent, and the organic solvent is selected from a mixture of one or more of dioxane, mesitylene, n-butanol, tetrahydrofuran, and benzyl alcohol;

[0019] In some preferred embodiments, the organic solvent is a mixed solvent of mesitylene and n-butanol in a volume ratio of 9:1-1:9.

[0020] In one embodiment of the present invention, the ratio of the solvent in step (1) to TAPP is 2 mL: 16.8 mg.

[0021] In one embodiment of the present invention, the mixing in step (1) is ultrasonic mixing, and the ultrasonic time is 5-60 minutes.

[0022] In some embodiments, the reaction system is mixed by ultrasound, the ultrasound time is 5-60 minutes, the reaction temperature is 20-200° C., and the reaction time is 1-7 days; after the product is naturally cooled to room temperature, the suspension is taken, centrifuged at high speed by a centrifuge, and the precipitate is washed with a solvent; after washing, it is dried in a vacuum oven to obtain a purple-black powder (TAPP-VIO).

[0023] In one embodiment of the present invention, the reaction solution in step (2) needs to be subjected to three cycles of freezing-nitrogen filling-vacuuming-thawing before the reaction.

[0024] In one embodiment of the present invention, the drying in step (3) is vacuum drying.

[0025] In some embodiments, the catalyst is an acetic acid solution;

[0026] In one embodiment of the present invention, the catalyst in step (1) is an acetic acid solution with a concentration of 6M;

[0027] Preferably, the amount of the catalyst is 10% (V / V) of the entire reaction system.

[0028] In some preferred embodiments, the separation step uses centrifugation;

[0029] In some preferred embodiments, the centrifugal separation step has a centrifugal speed of 8000-12000 rpm;

[0030] In some embodiments, the washing step uses one or more of tetrahydrofuran, N,N-dimethylformamide, and acetonitrile for washing;

[0031] In one embodiment of the present invention, the centrifugal speed in the centrifugal washing in step (3) is 8000-12000 rpm, and the number of washing precipitates is 3-6 times; the washing solvent is one or more of tetrahydrofuran and N,N-dimethylformamide.

[0032] The third object of the present invention is to provide the use of the cationic porphyrin-based covalent organic framework in the preparation of bactericidal preparations.

[0033] Furthermore, the bactericidal preparation is a bacteria-targeted phototherapy / chemotherapy synergistically enhanced bactericidal preparation;

[0034] Furthermore, the bactericidal preparation is a bactericidal preparation that promotes wound healing;

[0035] In some embodiments, the bactericidal preparation is a liquid preparation; it can be a drop or spray preparation.

[0036] The fourth object of the present invention is to provide a photothermal / photodynamic / chemical sterilization method for non-disease diagnosis and treatment, wherein the cationic porphyrin-based covalent organic framework described above or the cationic porphyrin-based covalent organic framework obtained by the preparation method described above is used as a sterilization material.

[0037] In one embodiment of the present invention, the photothermal / photodynamic sterilization method for non-disease diagnosis and treatment is to add TAPP-VIO for illumination;

[0038] Specifically, the method comprises the following steps: dissolving the porphyrin-based covalent organic framework material (TAPP-VIO) in a solvent, then mixing it with a bacterial solution, and then irradiating it under an appropriate light source for 20 minutes, and then spreading it on a solid culture medium by gradient dilution. After culturing for 12-24 hours, the colonies are counted to obtain a sterilization rate. The solvent is a liquid culture medium, the bacterial solution includes Staphylococcus aureus and Escherichia coli, and the light source is a white LED lamp.

[0039] Beneficial effects of the present invention:

[0040] (1) The cationic porphyrin-based covalent organic framework (TAPP-VIO) provided by the present invention can limit the distance between photosensitizer monomer molecules due to its special pore structure and the repulsive effect between cations, thereby reducing the self-aggregation quenching of the photosensitizer and ensuring the high-density aggregation of porphyrin molecules, and has good photothermal conversion performance and high efficiency. 1 O2 generation capability, achieving excellent photothermal and photodynamic effects, effectively preventing the self-aggregation quenching of the photosensitizer and thermal damage caused by continuous exposure to external light sources;

[0041] (2) The TAPP-VIO prepared by the present invention has a large surface area that enhances light absorption, and its ordered pores also help store oxygen and release reactive oxygen species, thereby improving the effect of photodynamic therapy;

[0042] (3) The preparation method of the cationic porphyrin-based covalent organic framework material provided by the present invention does not contain metal during the synthesis process, and the reaction to generate the imino bond is reversible, which provides the possibility for the subsequent degradation of the material. These characteristics give TAPP-VIO good biosafety. BRIEF DESCRIPTION OF THE DRAWINGS

[0043] Figure 1 : Schematic diagram of TAPP-VIO integrating photothermal / photodynamic / chemical sterilization prepared in Example 1;

[0044] Figure 2 : Experimental and simulated X-ray powder diffraction patterns of TAPP-VIO prepared in Example 1;

[0045] Figure 3 : Infrared spectra of monomers TAPP, VIO and TAPP-VIO prepared in Example 1;

[0046] Figure 4 : Transmission electron microscopy image of TAPP-VIO prepared in Example 1;

[0047] Figure 5 : X-ray powder diffraction pattern of TAPP-VIO prepared in Example 2;

[0048] Figure 6 : X-ray powder diffraction pattern of TAPP-VIO prepared in Example 3;

[0049] Figure 7 : X-ray powder diffraction pattern of TAPP-VIO prepared in Example 4;

[0050] Figure 8 : X-ray powder diffraction pattern of TAPP-VIO prepared in Example 5;

[0051] Fig. 9 : Photothermal effect diagram of TAPP-VIO prepared in Example 1;

[0052] Fig.10 : A graph showing the singlet oxygen generation capability of TAPP-VIO prepared in Example 1;

[0053] Fig.11 : Plate sterilization diagram of TAPP-VIO prepared in Example 1;

[0054] Fig.12: A diagram showing the in vivo wound treatment effect of TAPP-VIO prepared in Example 1. DETAILED DESCRIPTION

[0055] In order to further improve the understanding of the preparation process, technical features, etc. involved in the present invention, the present invention is further described below in conjunction with the embodiments. The following describes the preferred embodiments of the present invention. It should be understood that the embodiments are for better explanation of the present invention and are not used to limit the present invention.

[0056] 5,10,15,20-Tetrakis-(4-aminophenyl)porphyrin (TAPP): CAS No.: 22112-84-1, purchased from Jilin Academy of Sciences Yanshen Technology Co., Ltd.;

[0057] 4,4'-Dibenzaldehyde-bipyridine (VIO): CAS number: 1690360-53-2, purchased from Jilin Academy of Sciences Yanshen Technology Co., Ltd.

[0058] Example 1: Preparation of TAPP-VIO Materials

[0059] Preparation of a TAPP-VIO material integrating photothermal / photodynamic / chemical sterilization: The photosensitizer 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin TAPP is used as a structural unit to be restricted in the framework of a covalent organic skeleton, thereby achieving the effect of reducing its self-aggregation quenching while ensuring the density of the photosensitizer, thereby improving its photothermal and photodynamic effects; at the same time, the cationic group in another structural unit 4,4'-dibenzaldehyde-bipyridine VIO can give the material layers a certain electrostatic repulsion, thereby reducing the self-aggregation quenching of the photosensitizer, and on the other hand, its positive charge in the solution can be combined with the negatively charged membrane surface of the bacteria to fix the bacteria and reduce the bacterial transmission ability; the material preparation comprises the following steps:

[0060] (1) 21.9 mg of 4,4'-dibenzaldehyde-bipyridine (VIO, 0.05 mmol) and 16.8 mg of 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin (TAPP, 0.025 mmol) were added to a solvent consisting of mesitylene / n-butanol (1:1, v:v, 2.0 mL), and ultrasonically treated for 5 minutes. Then, 0.2 mL of acetic acid was added, and ultrasonic treatment was continued for another 5 minutes;

[0061] (2) The mixture was degassed three times by freeze pump-thaw cycles in a Pyrex tube and then sealed. Subsequently, the resulting mixture was reacted at 120° C. for 6 days;

[0062] (3) After cooling to room temperature, the final product (TAPP-VIO) was collected by centrifugation, washed five times with THF, and dried under vacuum at 50 °C;

[0063] The prepared TAPP-VIO was tested for performance. Figure 2 It shows that the characteristic diffraction peak of the cationic porphyrin-based covalent organic framework material (TAPP-VIO) is similar to the simulated AA stacking diffraction peak, but is quite different from the simulated AB stacking diffraction peak, indicating that the obtained porphyrin-based covalent organic framework is constructed in an AA stacking mode. Figure 3 The results showed that TAPP-VIO had a stretching vibration peak of -C=N- at 1595 nm, indicating that TAPP-VIO was successfully synthesized. Figure 4 It was shown that the size of TAPP-VIO is about 400nm, which is suitable for in vivo phototherapy and sterilization.

[0064] Embodiment 2:

[0065] The mixed solvent of mesitylene / n-butanol in Example 1 was adjusted to mesitylene / n-butanol (1:1, v:v), mesitylene / dioxane (1:1, v:v), mesitylene / ethanol (1:1, v:v), mesitylene / benzyl alcohol (1:1, v:v), o-dichlorobenzene / n-butanol, tetrahydrofuran / H2O, and the rest was kept consistent with Example 1 to obtain a porphyrin-based covalent organic framework material (TAPP-VIO).

[0066] The obtained porphyrin-based covalent organic framework material (TAPP-VIO) was subjected to performance testing, and the test results are as follows:

[0067] like Figure 5 As shown in the X-ray powder diffraction pattern, TAPP-VIO obtained with mesitylene / dioxane, mesitylene / ethanol, mesitylene / benzyl alcohol, o-dichlorobenzene / n-butanol or tetrahydrofuran / H2O as the reaction system has a lower characteristic diffraction peak at 3.5°, indicating that TAPP-VIO can be effectively prepared in a variety of solvent systems, and TAPP-VIO prepared with mesitylene / n-butanol as the reaction system has the highest crystallinity.

[0068] Embodiment 3:

[0069] The ratio of the mesitylene / n-butanol mixed solvent in Example 1 was adjusted to (9:1), (7:3), (1:1), (3:7), (1:9) (v:v) and the rest was kept consistent with Example 1 to obtain a porphyrin-based covalent organic framework material (TAPP-VIO).

[0070] The obtained porphyrin-based covalent organic framework material (TAPP-VIO) was subjected to performance testing, and the test results are as follows:

[0071] like Figure 6As shown in the X-ray powder diffraction pattern, the characteristic diffraction peak of TAPP-VIO obtained with the reaction systems of (9:1)(7:3), (3:7) and (1:9) at 3.5° is relatively low, indicating that TAPP-VIO can be effectively prepared by the mesitylene / n-butanol solvent system in the volume ratio range of (9:1)-(1:9), and the TAPP-VIO prepared by the mesitylene / n-butanol (1:1, v:v) reaction system has the highest crystallinity.

[0072] Embodiment 4:

[0073] The reaction temperature in Example 1 was adjusted to 60° C., 90° C. or 150° C., and the other conditions were kept consistent with Example 1 to obtain a porphyrin-based covalent organic framework material (TAPP-VIO).

[0074] The obtained porphyrin-based covalent organic framework material (TAPP-VIO) was subjected to performance testing, and the test results are as follows:

[0075] like Figure 7 The X-ray powder diffraction pattern shows that the characteristic diffraction peak of TAPP-VIO obtained by adjusting the reaction temperature to 60°C, 90°C or 150°C at 3.5° is lower, indicating that TAPP-VIO can be effectively prepared at a reaction temperature of 60-150°C, and the crystallinity of TAPP-VIO obtained at a reaction temperature of 120°C is the highest.

[0076] Embodiment 5:

[0077] The reaction time in Example 1 was adjusted to 2, 3, 4, 5, and 7 days, and the other conditions were kept consistent with Example 1 to obtain a porphyrin-based covalent organic framework material (TAPP-VIO).

[0078] The obtained porphyrin-based covalent organic framework material (TAPP-VIO) was subjected to performance testing, and the test results are as follows:

[0079] like Figure 8 The X-ray powder diffraction diagram shows that the characteristic diffraction peak of TAPP-VIO obtained by adjusting the reaction time to 2, 3, 4, 5, and 7 days at 3.5° is lower, indicating that TAPP-VIO can be effectively prepared when the reaction time is 2-7 days, and the crystallinity of TAPP-VIO obtained when the reaction time is 6 days is the highest.

[0080] Embodiment 6:

[0081] The TAPP-VIO prepared in Example 1 was used as a photosensitizer, and its photothermal and photodynamic properties were investigated.

[0082] Photothermal performance: TAPP-VIO was added at different concentrations (125 μg mL -1 , 250 μg mL-1 , 500 μg mL -1 and 750 μg mL -1 ) were dispersed in PBS, and 1 mL of the solution was added to a 48-well cell culture plate, which was then irradiated with white LED light for 20 min (1 mL of PBS was used as a control). A FLIR-50 thermal imager was used to record temperature changes during irradiation.

[0083] like Fig. 9 As shown, at 100mW·cm -2 After 20 min of white light irradiation, TAPP-VIO had good photothermal performance and showed concentration and time dependence. -1 , 250 μg mL -1 , 500 μg mL -1 and 750 μg mL -1 The temperature of TAPP-VIO solution systems with different concentrations increased by 10℃, 13℃, 17℃, and 19℃, respectively, while the temperature of PBS as the control group only increased by 3℃.

[0084] Photodynamic performance: 9,10-Anthracene dioyl-bis(methylene) dimaleic acid (ABDA) was used as the 1 As an indicator of O2, 100 μL of ABDA solution (5×10 -3 mol L -1 ) and different concentrations of TAPP-VIO solution (9.9 mL) were added into a 50 mL centrifuge tube (the final concentration of TAPP-VIO was 0 μg mL -1 , 125 μg mL -1 , 250 μg mL -1 , 500 μg mL -1 and 750 μg mL -1 Then use white LED light (50, 100 or 150 mW cm -2 ) irradiated the above solution for different time periods (0 min, 2.5 min, 5 min, 7.5 min, 10 min, 12.5 min, 15 min, 17.5 min and 20 min). Afterwards, 1 mL of the irradiated solution was taken out and centrifuged at the above time points, and the corresponding UV-vis absorption spectrum of the suspension was measured by a UV-vis-NIR spectrophotometer.

[0085] Fig.10 a shows 100 mW cm -2 Time-dependent absorption spectra of ABDA at 377 nm under different concentrations of TAPP-VIO under irradiation. Fig.10 b shows the concentration of 500 μg mL -1Time-dependent absorption spectra of TAPP-VIO and ABDA at 377 nm (A / A0) (A0 and A are the absorbance values ​​of ABDA before irradiation and after a certain period of irradiation, respectively).

[0086] like Fig.10 a and Fig.10 As shown in b, TAPP-VIO has good photodynamic performance and is time- and concentration-dependent. -2 After 20 minutes of white LED light exposure, 500 μg mL -1 The absorbance of TAPP-VIO treated ABDA decreased to approximately 20% of the initial value.

[0087] Embodiment 7:

[0088] Using TAPP-VIO prepared in Example 1 as a photosensitizer, its photothermal / photodynamic / chemical sterilization capabilities were investigated.

[0089] Plate coating experiment: The bacterial suspension was mixed with the TAPP-VIO solution and then cultured on a shaker at 37°C and 200 rpm for 30 minutes. Subsequently, the bacterial suspension containing TAPP-VIO was exposed to white LED light for 20 minutes. The bacterial suspension was extracted from each group, diluted gradiently and evenly spread on the solid culture medium. After culturing in a 37°C constant temperature incubator for 12 to 24 hours, the number of colonies was counted.

[0090] like Fig.11 As shown in Figure 2, TAPP-VIO exhibited significant bactericidal effect under white light irradiation, and the bactericidal effect was positively correlated with the irradiation time. -2 After irradiation with white light for 20 minutes, the sterilization rates of TAPP-VIO against Escherichia coli and Staphylococcus aureus reached 98.84% and 99.19%, respectively.

[0091] Embodiment 8:

[0092] The wound healing ability of TAPP-VIO prepared in Example 1 was investigated using the photosensitizer.

[0093] The wound healing properties of TAPP-VIO were explored using a mouse model based on Staphylococcus aureus infection. -1 TAPP-VIO was dripped onto the wound of mice and irradiated with 100 mW cm -2 The in vivo synergistic treatment experiment was performed by irradiating with white LED light for 20 min. The mice infected with Staphylococcus aureus were randomly divided into four groups (control group, TAPP-VIO, control + irradiation, TAPP-VIO + irradiation), and the wound area during the treatment was recorded.

[0094] like Fig.12 As shown in the figure, the wounds in the TAPP-VIO and TAPP-VIO+irradiation groups were smaller in terms of wound area. The wound morphology also showed the wound healing effect of TAPP-VIO. On the 10th day after irradiation, the wounds of the mice in the TAPP-VIO+irradiation group were not only completely healed, but also grew new pink skin, showing a significant synergistic therapeutic effect.

[0095] It should be understood that the above detailed embodiments of the present disclosure are only for the purpose of illustrating or explaining the principles of the present disclosure, rather than limiting the present invention. Therefore, any modifications, equivalent substitutions, and improvements made within the spirit and principles of the present disclosure should be included in the protection scope of the present invention.

Claims

1. A cationic porphyrin-based covalent organic framework with photothermal / photodynamic / chemical synergistic bactericidal ability, characterized in that: Having the structure shown in formula I; 2. The cationic porphyrin-based covalent organic framework with photothermal / photodynamic / chemical synergistic bactericidal ability according to claim 1, characterized in that: The cationic porphyrin-based covalent organic framework is prepared by reacting 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin monomers with 4,4'-dibenzaldehyde-bipyridine monomers.

3. The method for preparing a cationic porphyrin-based covalent organic framework having photothermal / photodynamic / chemical synergistic bactericidal ability according to claim 1 or 2, characterized in that: The following steps are involved: A solution containing 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin is mixed with a solution containing 4,4'-dibenzaldehyde-bipyridine, and then an acid or base is added as a catalyst. After mixing evenly, the mixture is reacted at a certain temperature, separated, washed, and dried to obtain the product TAPP-VIO.

4. The method for preparing a cationic porphyrin-based covalent organic framework having photothermal / photodynamic / chemical synergistic bactericidal ability according to claim 3, characterized in that: The molar ratio of the 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin to the 4,4'-dibenzaldehyde-bipyridine is 1:

2.

5. The method for preparing a cationic porphyrin-based covalent organic framework having photothermal / photodynamic / chemical synergistic bactericidal ability according to claim 3, characterized in that: The reaction is carried out in an organic solvent, and the organic solvent is selected from a mixture of one or more of dioxane, mesitylene, n-butanol, tetrahydrofuran, and benzyl alcohol.

6. The method for preparing a cationic porphyrin-based covalent organic framework having photothermal / photodynamic / chemical synergistic bactericidal ability according to claim 3, characterized in that: The reaction system is mixed by ultrasound, the ultrasound time is 5-60 minutes, the reaction temperature is 20-200° C., and the reaction time is 1-7 days.

7. The method for preparing a cationic porphyrin-based covalent organic framework having photothermal / photodynamic / chemical synergistic bactericidal ability according to claim 3, characterized in that: The catalyst is an acetic acid solution; the amount of the catalyst is 10% (V / V) of the entire reaction system.

8. The method for preparing a cationic porphyrin-based covalent organic framework having photothermal / photodynamic / chemical synergistic bactericidal ability according to claim 3, characterized in that: The separation step uses centrifugal separation, And / or, the washing step uses one or more of tetrahydrofuran, N,N-dimethylformamide, and acetonitrile for washing; And / or, the centrifugal speed is 8000-12000 rpm, and the precipitate is washed 3-6 times.

9. Use of the cationic porphyrin-based covalent organic framework according to any one of claims 1 to 2, or the cationic porphyrin-based covalent organic framework obtained by the preparation method according to any one of claims 3 to 8 in the preparation of a bactericidal preparation, characterized in that: The bactericidal preparation is a bacteria-targeted phototherapy / chemotherapy synergistically enhanced bactericidal preparation.

10. A photothermal / photodynamic / chemical sterilization method for non-disease diagnosis and treatment, characterized in that: The cationic porphyrin-based covalent organic framework described in claim 1 or 2 or the cationic porphyrin-based covalent organic framework prepared by the preparation method described in any one of claims 3 to 8 is used as a bactericidal material.

Citation Information

Patent Citations

  • Cation free radical type covalent organic frame material as well as preparation method and application thereof

    CN109180957A

  • Efficient photodynamically-sterilizing porphyrin covalent organic framework material and preparation method thereof

    CN113087863A

  • Photothermal / photodynamic / chemical sterilization integrated porphyrin-based covalent organic framework material as well as preparation method and application thereof

    CN115232271A

  • Covalent organic framework based on reversible oxidation reduction-catalysis and application of covalent organic framework in difunctional photoelectrochemical device

    CN118240160A

  • Use of derivatives of pentaphyrine as antimicrobial and disinfectant agents

    US20130172396A1